"synopsis" may belong to another edition of this title.
This book describes the modifications of DNA methylation in various major human disease groups, including nonneoplastic diseases that could provide a rationale to develop novel therapeutic strategies such as the use of DNA methylation as a potential tool for determining cancer risk.
In DNA Methylation in Complex Human Disease, expert authors review the possibilities of methyl-group-based epigenetic biomarkers of major diseases, tailored epigenetic therapies, and the future uses of high-throughput methylome technologies. This volume includes many pertinent advances in disease-bearing research, including therapies and the possibility of using methyl donors. DNA methylation is also discussed as a plasma and serum test for non-invasive screening, diagnostic and prognostic tests, as compared to biopsy-driven gene expression analysis. The authors also present the importance of high-throughput methylome analysis, as well as the advantages of DNA methylation as a biomarker over other molecular processes. DNA Methylation in Complex Human Disease is an excellent resource for basic biology and translational researchers interested in developmental biology, genetics health genomics, epigenesist in complex disease, and therapeutic possibilities, and developmental biologists, geneticists, biotechnologists, and epidemiologists have much to gain from this specialized and focused volume.
"About this title" may belong to another edition of this title.
Shipping:
£ 14.99
From United Kingdom to U.S.A.
Book Description Hardcover. Condition: New. Seller Inventory # 6666-ELS-9780124201941
Book Description Hardcover. Condition: Brand New. 1st edition. 552 pages. 9.00x6.25x1.25 inches. In Stock. Seller Inventory # __0124201946
Book Description Condition: new. Questo è un articolo print on demand. Seller Inventory # 1f8caed37c0c099a67a126ae6642ca15
Book Description Hardback. Condition: New. New copy - Usually dispatched within 4 working days. Seller Inventory # B9780124201941
Book Description Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -DNA Methylation and Complex Human Disease reviews the possibilities of methyl-group-based epigenetic biomarkers of major diseases, tailored epigenetic therapies, and the future uses of high-throughput methylome technologies. This volume includes many pertinent advances in disease-bearing research, including obesity, type II diabetes, schizophrenia, and autoimmunity. DNA methylation is also discussed as a plasma and serum test for non-invasive screening, diagnostic and prognostic tests, as compared to biopsy-driven gene expression analysis, factors which have led to the use of DNA methylation as a potential tool for determining cancer risk, and diagnosis between benign and malignant disease. Therapies are at the heart of this volume and the possibilities of DNA demethylation. In cancer, unlike genetic mutations, DNA methylation and histone modifications are reversible and thus have shown great potential in the race for effective treatments. In addition, the authors present the importance of high-throughput methylome analysis, not only in cancer, but also in non-neoplastic diseases such as rheumatoid arthritis. 552 pp. Englisch. Seller Inventory # 9780124201941
Book Description Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. DNA Methylation and Complex Human Disease reviews the possibilities of methyl-group-based epigenetic biomarkers of major diseases, tailored epigenetic therapies, and the future uses of high-throughput methylome technologies. This volume i. Seller Inventory # 37307268
Book Description Buch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - DNA Methylation and Complex Human Disease reviews the possibilities of methyl-group-based epigenetic biomarkers of major diseases, tailored epigenetic therapies, and the future uses of high-throughput methylome technologies. This volume includes many pertinent advances in disease-bearing research, including obesity, type II diabetes, schizophrenia, and autoimmunity. DNA methylation is also discussed as a plasma and serum test for non-invasive screening, diagnostic and prognostic tests, as compared to biopsy-driven gene expression analysis, factors which have led to the use of DNA methylation as a potential tool for determining cancer risk, and diagnosis between benign and malignant disease. Therapies are at the heart of this volume and the possibilities of DNA demethylation. In cancer, unlike genetic mutations, DNA methylation and histone modifications are reversible and thus have shown great potential in the race for effective treatments. In addition, the authors present the importance of high-throughput methylome analysis, not only in cancer, but also in non-neoplastic diseases such as rheumatoid arthritis. Seller Inventory # 9780124201941
Book Description Hardcover. Condition: new. New Copy. Customer Service Guaranteed. Seller Inventory # think0124201946
Book Description hardcover. Condition: New. New. book. Seller Inventory # D8S0-3-M-0124201946-6